The Selective Muscarinic M1 Agonist AF102B Decreases Levels of Total ABeta in Cerebrospinal Fluid of Patients with Alzheimer’s Disease

Publication Date: 

Nitsch RM, Deng M, Tennis M, Schoenfeld D and Growdon JH (2000).  The selective muscarinic m1 agonist af102b decreases levels of total abeta in cerebrospinal fluid of patients with alzheimer’s disease. Ann Neurol; 48: 913-918.